Hyperglycemia in GDM leads to reduced expression levels of miR-17-5p, upregulation of its target gene TXNIP, and subsequent activation of NLRP3 inflammasome, ultimately leading to the release of inflammatory cytokines and contributing to impaired trophoblast glucose uptake. Here, TXNIP is linked to gestational diabetes.